The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Dr Caroline Soliman completed a Bachelor of Biomedical Science at Monash University and graduated with first class Honours after undertaking an honours project in immunology at the Burnet Institute.  Dr Soliman subsequently undertook a PhD in the fields of immunology and structural biology with the Ramsland Laboratory at RMIT, where she aimed to structurally characterize antibody-carbohydrate interactions in cancer and infection. She was awarded her PhD in 2020 and began working as a Postdoctoral Researcher in the Godfrey Laboratory at the University of Melboure and the Doherty Institute. Dr Soliman is currently working on developing nanobodies for SARS-CoV-2.

  • Key Achievements
    • Throughout her PhD,  Dr Soliman published six first author papers, including four original research papers and two review papers, in addition to one middle author research paper. One of her first-author publications was featured on the Journal of Biological Chemistry (JBC) cover in April 2018, and until late 2019 it held the highest Altmetric score of all papers published in this journal.

      Dr Soliman has presented her work at local and international conferences, and in 2019 she was an invited speaker at the ASBMB international conference where she received a JBC Herbert Tabor Early Career Investigator Award.

    Publications
    Loading ORCID data…